Prosecution Insights
Last updated: April 19, 2026

Exelixis Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
3
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18672226 MEK INHIBITORS AND METHODS OF THEIR USE CHEN, PO-CHIH 1621 Final Rejection May 23, 2024
18018864 MULTISPECIFIC BINDING AGENTS AND USES THEREOF BRISTOL, LYNN ANNE 1643 Final Rejection Jan 30, 2023
18018860 CD47 BINDING AGENTS AND USES THEREOF DARPOLOR, JOSEPHINE KEBBEH 1642 Non-Final OA Jan 30, 2023
17800084 COMPOUNDS AND METHODS OF USE BELL, SARA ELIZABETH 1625 Final Rejection Aug 16, 2022

Managing Exelixis Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month